Our postdoctoral fellow Dr. Victor V. Onecha delivered an outstanding talk last Friday at the 63rd Annual Conference of the Particle Therapy Co-Operative Group (PTCOG), held this year in Buenos Aires, Argentina.
Victor presented recent work from our lab on DNA damage modeling as a biologically-grounded quantity for treatment planning across particle therapy modalities. His talk drew attention and sparked discussions on how damage-based metrics could improve cross-modality comparisons and optimize biological dose delivery, especially in the context of high-LET radiations like protons and carbon ions.
PTCOG is the premier international meeting for experts in clinical and research aspects of particle therapy. Having our work featured on this stage reflects not only the quality of Victor’s research but also the growing interest in integrating radiobiological modeling into clinical workflows.
Congratulations to Victor on a sharp presentation and thanks to all who contributed to the discussions that followed. We’re excited to continue advancing the conversation on biologically-informed planning in particle therapy.
